[
    {
        "title": "Why Indian pharma needs to elevate ESG for sustainable future",
        "effective_date": "2025-01-31T12:35:02",
        "source": "Forbes India",
        "document_url": "https://www.forbesindia.com/article/isbinsight/why-indian-pharma-needs-to-elevate-esg-for-sustainable-future/95192/1",
        "geographic_coverage": [
            "India"
        ],
        "about": "Indian pharmaceutical companies lag behind global peers in ESG practices, facing regulatory, awareness, and resource challenges. Strengthening ESG performance can attract investments and promote sustainable development in the sector.",
        "description": "The article discusses the current state of ESG in Indian pharmaceuticals, highlighting the challenges faced by Indian pharma companies in implementing effective ESG strategies. It emphasizes the need for Indian companies to learn from global leaders and adopt best practices to improve their ESG performance. The article also provides actionable recommendations for Indian pharma companies to enhance their ESG initiatives.",
        "report_period": {
            "start_year": 2025,
            "end_year": 2025
        },
        "key_metrics": {
            "emissions_reduction": {
                "value": "55",
                "data_type": "percentage",
                "context": "Reduction in Scope 1 and 2 CO2 emissions by a Japanese subsidiary of a global pharma company from its 2019 baseline.",
                "unit": "%",
                "source": null,
                "time_period": "2019",
                "comparison": null,
                "report_reference": null
            },
            "renewable_energy_reliance": {
                "value": "97",
                "data_type": "percentage",
                "context": "Reliance on renewable energy by a Japanese subsidiary of a global pharma company.",
                "unit": "%",
                "source": null,
                "time_period": null,
                "comparison": null,
                "report_reference": null
            },
            "gender_parity_goal": {
                "value": "2025",
                "data_type": "year",
                "context": "Target year for achieving gender parity in leadership by leading global companies.",
                "unit": null,
                "source": null,
                "time_period": null,
                "comparison": null,
                "report_reference": null
            }
        },
        "reports_cited": [
            "MSCI (2021) ESG and Performance",
            "World Economic Forum Lighthouse factory"
        ],
        "imagedata": [
            "https://images.forbesindia.com/media/images/2025/Jan/img_242697_shutterstock_2142708213_bg.jpg",
            "https://images.forbesindia.com/media/images/2025/Jan/img_242252_rajeevjuneja_jul24_av01copy.jpg",
            "https://images.forbesindia.com/media/images/2024/May/img_235090_pharma.jpg",
            "https://images.forbesindia.com/media/images/2024/Apr/img_232725_vasnarasimhan.jpg",
            "https://images.forbesindia.com/media/images/2025/Jan/img_242695_indianpharmaelevatingesgforsustainablefuture-3.jpg"
        ]
    }
]